Articles related to NURSING

Malnutrition is a pressing issue in cancer care, with studies highlighting its significant influence on treatment outcomes and mortality rates. Exploring strategies for prevention, treatment, and ongoing support is vital to improve patient quality of life and success in cancer treatment.

In light of the Supreme Court’s recent ruling, it’s more imperative than ever for healthcare practitioners to fortify their commitment towards equitable healthcare, unmask health disparities, and staunchly combat racial prejudice and discrimination.

Join this crucial journey to broaden your comprehension of CAR T-cell therapy, CRS and ICANS management, and learn how to utilize this knowledge for better patient outcomes in the battle against relapsed/refractory multiple myeloma.

The case of Ms E and the ‘Dr. Sarah’ controversy highlights the necessity for clear, unambiguous professional representation in the medical field. This unfolding situation serves as a reminder of the potential consequences when professional boundaries are blurred.

Medication Prescribing Error: A Medical Malpractice Case with Tragic Consequences In an evolving healthcare ecosystem, the need for rigorous medication dosing protocols based on patient-specific conditions is underlined in a recent medical malpractice case involving a nurse practitioner and an unfortunate prescription error.

Discover a holistic perspective on advanced bladder and renal cell cancers management, encompassing everything from pathogenesis to adverse event mitigation. Let’s dive into the “Advanced Bladder and Renal Cell Cancers Management” webcast, released on April 30, 2023, offering valuable 1.00 ANCC contact hour, inclusive of 0.75 pharmacology hours. Presented by expert Mary W. Dunn, MSN, RN, OCN, NP-C from the University of North Carolina, this program targets oncology nurses, nurse navigators, advanced nursing providers, and nurses from other cancer-related subspecialties. It remains available until April 30, 2024, leaving ample time to gain this crucial knowledge. Primarily, this webcast zeroes in on bladder cancer (BC), a malignancy notorious for its high mortality rate, and renal cell carcinoma (RCC), a top-10 common cancer. Unfortunately, BC’s 5% survival rate for metastatic disease cases paints a grim picture. Luckily, hope emerges in the form of novel therapeutic agents for advanced, recurrent, and metastatic BC and RCC. Next, the program navigates through the pathogenesis of these cancers. Equipped with this knowledge, healthcare providers can better understand the intricacies of disease progression. As the treatment landscape rapidly evolves, so does the complexity in selection, sequencing, and adverse event (AE) management. Thus, the webcast outlines how to […]